Скачать или смотреть FY2024: Your Support and How it Was Used | Karen Peterson, CRI ImmunoAdvocate

Karen was diagnosed with stage 1 triple-negative breast cancer. After undergoing traditional treatments, her cancer returned in 2017 as metastatic, accompanied by a devastating prognosis of just 18 to 24 months to live. Refusing to accept this, Karen sought information about immunotherapy and other treatment options and discovered CRI. She found a phase 1 clinical trial that offered new hope.

Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.